RecruitingNot applicableNCT05538338

Platelet Rich Plasma for Insufficient Endometrium

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Reproductive Medicine Associates of New Jersey
Intervention
Platelet Rich Plasma Intrauterine infusion(other)
Enrollment
62 target
Eligibility
18-45 years · FEMALE
Timeline
20222025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05538338 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials